June 2019

ContraVir’s stock plunges after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals – MarketWatch

ContraVir’s stock plunges after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals MarketWatch Shares of ContraVir Pharmaceuticals Inc. plunged Tuesday, to cap off a whipsaw week for investors that included upbeat results of drug studies and SEC filings …

ContraVir’s stock plunges after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals – MarketWatch Read More »

Scroll to Top